JPRN-UMIN000033255已完成未知
Pilot Study of efficacy and safety of nalfurafine hydrochloride for jaundice associated pruritus - Pilot Study of efficacy and safety of nalfurafine hydrochloride for jaundice associated pruritus
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patient's consciousness are not alert. Presence of hypersensitivity to nalfurafine hydrochloride and/or fexofenadine hydrochloride. Presence of other dermatosis except for jaundice associated pruritis. Presence of sever organopathy and/or drug allergy. Patients who pregnant or possibility of pregnant, lactating and desire for childbearing. Difficult to ingestion. Ineligible cases are judged by researchers.
研究者
相似试验
已完成
3 期
A clinical trial to study the effects of two drugs, naftifine and terbinafine in patients with dermatophytosis.CTRI/2009/091/000679Sun Pharmaceutical Industries Ltd.
尚未招募
不适用
Effect of nalfurafine hydrochloride in patients with chronic liver disease with refractory pruritus on sleep disorders: A study protocol for prospective interventional studyJPRN-UMIN000028161Hyogo college of medicine50
已完成
3 期
Efficacy and Safety Study of TRK-820 to Treat Conventional-treatment-resistant Pruritus in Patients Receiving HemodialysisConventional-treatment-resistant Pruritus in Patients Receiving HemodialysisNCT01513161SK Chemicals Co., Ltd.104
已完成
4 期
Phase 4 study of nalfurafine hydrochloride for pruritus in patients with PBCprimary biliary cholangitis, primary sclerosing cholangitisJPRN-UMIN000019296Teikyo University School of Medicine200
Unknown
3 期
A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating TabletUremic PruritusNCT04728984Shenyang Sunshine Pharmaceutical Co., LTD.135